Connect Biopharma Holdings Limited
CNTB
$2.05
-$0.10-4.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.90M | -10.27M | -11.64M | -11.64M | 14.85M |
| Total Depreciation and Amortization | 171.00K | 173.00K | 92.00K | 92.00K | 162.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 663.00K | 727.00K | 2.53M | 2.53M | 1.98M |
| Change in Net Operating Assets | -526.00K | -587.00K | 1.20M | 1.20M | -24.68M |
| Cash from Operations | -12.59M | -9.96M | -7.82M | -7.82M | -7.70M |
| Capital Expenditure | -303.00K | -81.00K | -157.00K | -157.00K | -290.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 2.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.43M | -20.56M | -7.71M | -7.71M | 3.50M |
| Cash from Investing | 5.13M | -20.64M | -7.86M | -7.86M | 3.21M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 74.00K | 74.00K | -- |
| Issuance of Common Stock | 161.00K | 2.00K | 62.50K | 62.50K | 121.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 161.00K | 2.00K | 136.50K | 136.50K | 121.00K |
| Foreign Exchange rate Adjustments | 224.00K | 75.00K | -252.50K | -252.50K | 102.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.08M | -30.52M | -15.80M | -15.80M | -4.26M |